Caredx, INC Form 4 insider transactions

CareDx's Secretary and General Counsel, Jeffrey Adam Novack, sold a portion of his shares under a pre-arranged 10b5-1 trading plan.

CareDx's Secretary and General Counsel, Jeffrey Adam Novack, reports the disposal of 452 common stock shares to cover tax obligations related to vesting restricted stock units on November 6, 2024.

Director George Bickerstaff exercised stock options to acquire CareDx shares at prices of $5.85 and $5.49 on November 1, 2024.

Jeffrey Adam Novack, Secretary and General Counsel of CareDx, Inc., reported disposing of 1,905 shares of common stock on November 1, 2024, to cover tax withholding obligations.

Abhishek Jain, CFO of CareDx, Inc., disposed of 7,371 shares of common stock on November 1, 2024, to cover tax obligations related to vesting restricted stock units.

Director Michael Goldberg acquired 837 shares of CareDx common stock on October 4, 2024, as part of a quarterly grant in lieu of cash compensation.

CareDx's Chief Operating Officer, Keith Kennedy, reports acquisition of restricted stock units and stock options, along with the disposal of common stock.

Jessica Meng, Chief Commercial Officer of CareDx, Inc., reports the acquisition of restricted stock units and stock options.

CareDx's Chief Financial Officer, Abhishek Jain, reported a transaction involving the withholding of common stock to cover tax obligations.

Abhishek Jain, CFO of CareDx, Inc., reports the disposal of 697 shares of common stock to cover tax obligations related to vesting restricted stock units on September 6, 2024.

Alexander L. Johnson, President of Patient and Testing Services at CareDx, Inc., executed stock options and subsequently sold shares on August 20 and 21, 2024.

Director Peter Maag reports exercising stock options and selling shares of CareDx, Inc. on August 20, 2024.

Alexander L. Johnson, President of Patient and Testing Services at CareDx, Inc., sold a portion of his holdings in a series of transactions on August 19, 2024.

CareDx's Chief Financial Officer, Abhishek Jain, disposed of 7,371 shares of common stock on August 1, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Alexander L. Johnson, President of Patient and Testing Services at CareDx, Inc., reported the disposal of 7,371 shares of common stock on August 1, 2024, to cover tax withholding obligations.

Jeffrey Adam Novack, Secretary and General Counsel of CareDx, Inc., sold 1,905 shares of common stock on August 1, 2024, to cover tax withholding obligations.

Alexander L. Johnson, President of Patient and Testing Services at CareDx, Inc., reports the withholding of 1,690 shares to cover tax obligations related to vesting restricted stock units.

Director Peter Maag acquired 1,034 shares of CareDx, Inc. common stock on July 8, 2024, through an automatic quarterly grant in lieu of cash compensation.

Michael Goldberg, a director at CareDx, Inc., acquired 2,963 shares of common stock on July 8, 2024, as part of the company's Outside Director Compensation Policy.

Alexander L. Johnson, President of Patient and Testing Services at CareDx, Inc., reports disposition of 634 shares to cover tax obligations.

Jeffrey Adam Novack, Secretary and General Counsel of CareDx, Inc., sold 183 shares of common stock on July 8, 2024, to cover tax withholding obligations.

Christine Cournoyer, a director at CareDx, Inc., reported the acquisition of restricted stock units and stock options.

William A. Hagstrom, a director of CareDx, Inc., filed an amendment to a Form 4 to correct the exercise price of a stock option granted on June 14, 2024.

Hannah Valantine, a director of CareDx, Inc., filed an amendment to a Form 4, correcting the exercise price of a stock option.

Michael Goldberg, a director at CareDx, Inc., filed an amendment to a previous SEC Form 4 to correct the exercise price of a stock option.

Arthur Torres, a director at CareDx, Inc., filed an amendment to a Form 4 to correct the exercise price of a stock option.

Fred E. Cohen, a director of CareDx, Inc., amended a previous Form 4 filing to correct the exercise price of a stock option.

Peter Maag, a director at CareDx, Inc., filed an amendment to a Form 4 to correct the exercise price of a stock option.

George Bickerstaff, a director at CareDx, Inc., filed an amendment to a previous SEC Form 4 to correct the exercise price of a stock option.

Richard Bryan Riggsbee, a director at CareDx, Inc., filed an amendment to a Form 4, correcting the exercise price of stock options acquired on June 13 and June 14, 2024.